| 478 |
Activation, NRF2
Short Name
Activation, NRF2
|
1 |
Molecular |
Nov 29, 2016 |
Sep 16, 2017 |
61: NFE2L2/FXR activation leading to hepatic steatosis
|
| 477 |
Decreased, Ketogenesis
Short Name
Decreased, Ketogenesis
|
1 |
Cellular |
Nov 29, 2016 |
Sep 16, 2017 |
60: NR1I2 (Pregnane X Receptor, PXR) activation leading to hepatic steatosis
|
| 474 |
Down Regulation, HMGCS2
Short Name
Down Regulation, HMGCS2
|
1 |
Molecular |
Nov 29, 2016 |
Sep 16, 2017 |
60: NR1I2 (Pregnane X Receptor, PXR) activation leading to hepatic steatosis
|
| 472 |
Down Regulation, CPT1A
Short Name
Down Regulation, CPT1A
|
1 |
Molecular |
Nov 29, 2016 |
Sep 16, 2017 |
2 AOPs
|
| 471 |
Inhibition, FoxA2
Short Name
Inhibition, FoxA2
|
1 |
Molecular |
Nov 29, 2016 |
Sep 16, 2017 |
60: NR1I2 (Pregnane X Receptor, PXR) activation leading to hepatic steatosis
|
| 470 |
Up Regulation, Acetyl-CoA carboxylase-1 (ACC-1)
Short Name
Up Regulation, Acetyl-CoA carboxylase-1 (ACC-1)
|
1 |
Molecular |
Nov 29, 2016 |
Sep 16, 2017 |
58: NR1I3 (CAR) suppression leading to hepatic steatosis
|
| 468 |
Inhibition, PPAR alpha
Short Name
Inhibition, PPAR alpha
|
1 |
Molecular |
Nov 29, 2016 |
Sep 16, 2017 |
58: NR1I3 (CAR) suppression leading to hepatic steatosis
|
| 467 |
Increased, LDL uptake
Short Name
Increased, LDL uptake
|
1 |
Cellular |
Nov 29, 2016 |
Sep 16, 2017 |
2 AOPs
|
| 466 |
Up Regulation, LDLR (low density lipoprotein receptor)
Short Name
Up Regulation, LDLR (low density lipoprotein receptor)
|
1 |
Molecular |
Nov 29, 2016 |
Sep 16, 2017 |
57: AhR activation leading to hepatic steatosis
|
| 465 |
Increased, Fatty acid influx
Short Name
Increased, FA Influx
|
1 |
Cellular |
Nov 29, 2016 |
Feb 24, 2026 |
6 AOPs
|
| 463 |
Up Regulation, FAS
Short Name
Up Regulation, FAS
|
1 |
Molecular |
Nov 29, 2016 |
Sep 16, 2017 |
58: NR1I3 (CAR) suppression leading to hepatic steatosis
|
| 462 |
Up Regulation, SCD-1
Short Name
Up Regulation, SCD-1
|
1 |
Molecular |
Nov 29, 2016 |
Sep 16, 2017 |
4 AOPs
|
| 461 |
Suppression, HNF4alpha
Short Name
Suppression, HNF4alpha
|
1 |
Molecular |
Nov 29, 2016 |
Sep 16, 2017 |
59: HNF4alpha suppression leading to hepatic steatosis
|
| 460 |
Increased, Fatty acid uptake
Short Name
Increased, Fatty acid uptake
|
0 |
Cellular |
Nov 29, 2016 |
Dec 3, 2016 |
None
|
| 459 |
Increase, Liver steatosis
Short Name
Increase, Liver steatosis
|
1 |
Organ |
Nov 29, 2016 |
Feb 11, 2026 |
22 AOPs
|
| 458 |
Increased, De Novo FA synthesis
Short Name
Increased, De Novo FA synthesis
|
1 |
Cellular |
Nov 29, 2016 |
Sep 16, 2017 |
2 AOPs
|
| 457 |
Activation, SREBF1
Short Name
Activation, SREBF1
|
2 |
Molecular |
Nov 29, 2016 |
Sep 16, 2017 |
2 AOPs
|
| 456 |
Suppression, Constitutive androstane receptor, NR1I3
Short Name
Suppression, Constitutive androstane receptor, NR1I3
|
1 |
Molecular |
Nov 29, 2016 |
May 25, 2026 |
58: NR1I3 (CAR) suppression leading to hepatic steatosis
|
| 454 |
Increased, Triglyceride formation
Short Name
Increased, Triglyceride formation
|
2 |
Cellular |
Nov 29, 2016 |
Sep 16, 2017 |
2 AOPs
|
| 451 |
Inhibition, Mitochondrial fatty acid beta-oxidation
Short Name
Inhibition, Mitochondrial fatty acid beta-oxidation
|
1 |
Molecular |
Nov 29, 2016 |
Sep 16, 2017 |
3 AOPs
|
| 450 |
Decrease, Very low-density lipoprotein export capacity
Short Name
Decrease, VLDL export capacity
|
1 |
Cellular |
Nov 29, 2016 |
Feb 12, 2026 |
57: AhR activation leading to hepatic steatosis
|
| 447 |
Reduction, Cholesterol transport in mitochondria
Short Name
Reduction, Cholesterol transport in mitochondria
|
1 |
Cellular |
Nov 29, 2016 |
Sep 16, 2017 |
2 AOPs
|
| 446 |
Reduction, fetal/adult testosterone
Short Name
Reduction of testosterone
|
1 |
Tissue |
Nov 29, 2016 |
May 17, 2023 |
476: Adverse Outcome Pathways diagram related to PBDEs associated male reproductive toxicity
|
| 445 |
Respiratory distress/arrest
Short Name
Respiratory distress/arrest
|
1 |
Organ |
Nov 29, 2016 |
Dec 20, 2019 |
2 AOPs
|
| 444 |
Increased, Atrioventricular block and bradycardia
Short Name
Increased, Atrioventricular block and bradycardia
|
2 |
Organ |
Nov 29, 2016 |
Sep 16, 2017 |
94: Sodium channel inhibition leading to congenital malformations
|